Chevron is preparing to ramp up investments in South Korea, focusing heavily on refining and petrochemical projects to strengthen its downstream portfolio in Asia. Speaking at the Asia Pacific Petroleum Conference on Monday, Brant Fish, Chevron’s president of international downstream, said the U.S. oil giant sees South Korea as a key hub for growth in petrochemicals and heavy oil upgrading.
Fish explained that Chevron’s strategy will vary by market. In South Korea, the company plans to prioritize large-scale investments aimed at expanding refining capacity and petrochemical production. Meanwhile, in Singapore, Chevron has chosen a different approach, opting against heavy capital spending. Instead, the company expects to maximize returns by leveraging existing assets and operating efficiencies across market cycles.
The move reflects Chevron’s broader strategy to position itself competitively within Asia’s evolving energy landscape. With demand for refined products and advanced petrochemicals projected to rise in the region, South Korea offers a strong opportunity for growth and innovation. By investing in advanced refining technologies and heavy oil upgrading, Chevron aims to capture greater value in downstream operations and enhance long-term profitability.
Chevron’s focus on petrochemicals aligns with global energy trends, as major oil companies shift resources toward higher-margin products that support industrial growth and consumer markets. Petrochemicals are essential for producing plastics, synthetic materials, and other products tied to rising demand in Asia.
While Singapore will continue to play an important role in Chevron’s downstream operations, South Korea stands out as the company’s next investment-heavy market in Asia. This targeted strategy underscores Chevron’s effort to balance efficiency with growth, ensuring it adapts to changing energy markets while delivering strong returns to shareholders.


Nike Beats Q3 Estimates but China Weakness and Margin Pressure Weigh on Outlook
Trump Administration Plans 100% Tariffs on Pharmaceutical Imports
McDonald's and Restaurant Brands International Face Headwinds Amid Iran Conflict and Rising Costs
Elon Musk Ties SpaceX IPO Access to Mandatory Grok AI Subscriptions
Private Credit Under Pressure: Is a Slow-Motion Crisis Unfolding?
OpenAI Executive Shake-Up Ahead of Anticipated 2026 IPO
KPMG UK Cuts 440 Audit Jobs Amid Low Attrition and Cooling Professional Services Demand
CTOC Adds 3,000 Doctors, 500 Hospitals Ahead of Liquidity Push
Jefferies Upgrades Sodexo to Buy With €55 Target After Historic CEO Appointment
First Western Ship Transits Strait of Hormuz Since Iran War Began
Microsoft's $10 Billion Japan Investment: AI Infrastructure and Data Sovereignty Push
Annie Altman Amends Sexual Abuse Lawsuit Against OpenAI CEO Sam Altman
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
SoftwareONE Posts 22.5% Revenue Surge in 2025 on Crayon Acquisition
TSMC Japan's Second Fab to Produce 3nm Chips by 2028
Apple Turns 50: From Garage Startup to AI Crossroads
Ukrainian Drones and the #MadeByHousewives Movement: Kyiv Fires Back at Rheinmetall CEO 



